Medical News

RSS

Glucocorticoid therapies promote functional recovery of blood-brain barrier after blast injury

Barclay Morrison III, associate professor of biomedical engineering at Columbia Engineering, has led the first study to determine underlying biological mechanisms that promote functional recovery of the blood-brain barrier (BBB) after blast injury. The research demonstrates that treatment with the glucocorticoid, dexamethasone, after primary blast injury promotes rapid recovery of an in vitro model of the BBB, a highly restrictive semi-permeable barrier whose primary function is to maintain the brain's microenvironment and protect it from potentially toxic substances.

12 Mar 2015

Implantable defibrillators help patients with hypertrophic cardiomyopathy live longer

Newly published research led by the Minneapolis Heart Institute Foundation and Tufts Medical Center in Boston shows that implantable defibrillators (ICDs), along with other modern treatments, have reduced mortality rates and are helping patients with hypertrophic cardiomyopathy (HCM) live longer, including normal life expectancy.

12 Mar 2015

SHL Telemedicine, USCI sign distribution agreement for smartheart device in Japan

SHL Telemedicine Ltd., a leading provider and developer of advanced personal telemedicine solutions, today announced that it has signed a distribution agreement for its innovative smartheart device with USCI Holdings, Inc., of Japan.

11 Mar 2015

Two researchers to receive Potamkin Prize for research on Alzheimer's disease

The American Academy of Neurology and the American Brain Foundation are awarding the 2015 Potamkin Prize for Research in Pick's, Alzheimer's and Related Diseases to Peter Davies, PhD, of the Feinstein Institute for Medical Research in Manhasset, NY, and Reisa A. Sperling, MD, of the Brigham and Women's Hospital and Massachusetts General Hospital in Boston.

11 Mar 2015

Mylan releases Fentanyl Transdermal System 37.5, 62.5 and 87.5 mcg/hr in U.S.

Mylan N.V. and Mylan Inc. today announced the U.S. launch of its Fentanyl Transdermal System 37.5, 62.5 and 87.5 mcg/hr, adding to its existing offering of Fentanyl Transdermal System 12, 25, 50, 75 and 100 mcg/hr.

11 Mar 2015

Fourth patient dosed in Benitec Biopharma's Phase I/IIa hepatitis C trial

Benitec Biopharma, a biopharmaceutical company focused on providing potentially curative therapies with its proprietary gene-silencing technology called ddRNAi or "expressed RNAi," today announced that the fourth patient in the company's Phase I/IIa dose escalation clinical trial of its lead program TT-034 for treating hepatitis C was dosed at the Duke Clinical Research Unit.

11 Mar 2015

BeiGene chooses SAFC's CHOZN Platform to support oncology drug development

Sigma-Aldrich Corporation today announced that SAFC Commercial, its custom manufacturing services business unit, has entered a commercial sales and service contract with leading biopharmaceutical company, BeiGene.

11 Mar 2015

Recruitment completed for Phase III PROUD-PV trial of P1101 for treatment of polycythemia vera

PharmaEssentia (Taipei, Taiwan) and AOP Orphan (Vienna, Austria) announce the completion of recruitment for the Phase III trial PROUD-PV to support global marketing of P1101 (Ropeginterferon alfa-2b), a novel, long-acting, mono-pegylated interferon for the first line treatment of polycythemia vera.

11 Mar 2015

Green Cross makes investment in cell therapy sector in China

Green Cross, a South Korean biopharmaceutical company, today announced that it had signed MOU on the 6th of March with the Guizhou provincial government of China for the investment in the cell therapy sector in China.

11 Mar 2015

Chromogenex US, LiLa sign distribution agreement for i-lipo and i-lipo Ultra body sculpting systems

Chromogenex US, Inc., of Howell, Michigan, the sister company of Chromogenex Technologies, Ltd., and LiLa Enterprise, LLC of Suwanee, Georgia, announced today a strategic alliance wherein Chromogenex US appoints LiLa the exclusive distributor for the i- lipo and i-lipo Ultra body sculpting systems that employ low level laser technology for smoothing cellulite, fat reduction and body shaping treatments.

11 Mar 2015

Xylem’s YSI biochemistry analyzer is effective tool for cell culture and cancer research

Specifically for oncology drug development applications, the YSI 2950 biochemistry analyzer is used to measure analytes such as glucose, glutamine, glutamate, lactate, providing a simple, automated analysis of bioprocess cell culture samples, with accurate results in less than a minute.

11 Mar 2015

Xylem’s YSI biochemistry analyzer ideal for food process applications

The 2900 Series Biochemistry Analyzers from YSI, a Xylem brand, deliver rapid, accurate biochemistry analysis and provide several data management solutions for making process and quality assurance decisions in food process applications.

11 Mar 2015

Avalon Assisted Living receives prestigious national quality award

Avalon Assisted Living at Bridgewater was recognized by the American Health Care Association and National Center for Assisted Living as one of only four NCAL members in the country to receive this prestigious national quality award.

11 Mar 2015

Intraprise Healthcare launched to provide strategic solutions to healthcare market

Intraprise Solutions, a technology professional services firm with nearly two decades of experience in health information technology today announced the launch of Intraprise Healthcare, a dedicated business division within Intraprise Solutions. Intraprise Healthcare provides strategic consulting and software engineering solutions to the healthcare market.

11 Mar 2015

USAP, Pinnacle announce new partnership with Excel Anesthesia

U.S. Anesthesia Partners, the nation's largest anesthesia-focused, single-specialty physician services organization, and Pinnacle Anesthesia Consultants of Dallas, Texas today announced their partnership with Excel Anesthesia, P.A.

11 Mar 2015

UVA, Novant Health to jointly create Northern Virginia regional health system

University of Virginia Health System and Novant Health are in discussions to create a Northern Virginia regional health system. The proposed agreement would include UVA Culpeper Hospital and all of Novant Health's Virginia facilities, including Novant Health Haymarket Medical Center, Novant Health Prince William Medical Center and Novant Health Cancer Center.

11 Mar 2015

University of Cambridge's Alastair Compston wins 2015 John Dystel Prize for MS Research

The American Academy of Neurology and the National Multiple Sclerosis Society are awarding the 2015 John Dystel Prize for MS Research to Alastair Compston, MBBS, PhD, Professor of Neurology at the University of Cambridge.

11 Mar 2015

One World Cannabis, Sheba Academic Medical Center ink collaboration agreement

OWC Pharmaceutical Research Corp.'s wholly owned subsidiary One World Cannabis Ltd. signed a collaboration agreement with Sheba Academic Medical Center, the largest hospital in Israel and in the Middle East.

11 Mar 2015

Andor Neo sCMOS camera is perfect partner for correlative microscopy

CD44 is recognised as an important cell surface receptor involved in the adhesion of circulating leukocytes to endothelium, a process that is critical for their trafficking in the vasculature. Now, a Japanese group of researchers using an ultra-sensitive Andor Neo sCMOS camera in their correlative microscopy set-up has demonstrated that microvilli projections around the cell surface mediate this adhesion.

From Andor Technology Ltd. 11 Mar 2015

Weak spots in ebola’s defenses: an interview with Dr. Andrew Ward

There are hundreds of other antibodies against Ebola that we are in the process of imaging using the electron microscope. We are looking for new sites of vulnerability as well as subtle differences in the way the known sites are attacked. In particular we are looking for antibodies that the virus is unlikely to escape from when it mutates.

11 Mar 2015

Medical News

Glucocorticoid therapies promote functional recovery of blood-brain barrier after blast injury

Implantable defibrillators help patients with hypertrophic cardiomyopathy live longer

SHL Telemedicine, USCI sign distribution agreement for smartheart device in Japan

Two researchers to receive Potamkin Prize for research on Alzheimer's disease

Mylan releases Fentanyl Transdermal System 37.5, 62.5 and 87.5 mcg/hr in U.S.

Fourth patient dosed in Benitec Biopharma's Phase I/IIa hepatitis C trial

BeiGene chooses SAFC's CHOZN Platform to support oncology drug development

Recruitment completed for Phase III PROUD-PV trial of P1101 for treatment of polycythemia vera

Green Cross makes investment in cell therapy sector in China

Chromogenex US, LiLa sign distribution agreement for i-lipo and i-lipo Ultra body sculpting systems

Xylem’s YSI biochemistry analyzer is effective tool for cell culture and cancer research

Xylem’s YSI biochemistry analyzer ideal for food process applications

Avalon Assisted Living receives prestigious national quality award

Intraprise Healthcare launched to provide strategic solutions to healthcare market

USAP, Pinnacle announce new partnership with Excel Anesthesia

UVA, Novant Health to jointly create Northern Virginia regional health system

University of Cambridge's Alastair Compston wins 2015 John Dystel Prize for MS Research

One World Cannabis, Sheba Academic Medical Center ink collaboration agreement

Andor Neo sCMOS camera is perfect partner for correlative microscopy

Weak spots in ebola’s defenses: an interview with Dr. Andrew Ward

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News